Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The study is recruiting 50 patients initiating or switching to Atripla and comparing them to 250 individuals previously followed in a prospective study of HIV+ low income individuals recruited from homeless shelters, single room occupancy hotels and free meal food lines as part of the UCSF Reach Study. Adherence will be measured through monthly unannounced pill counts and electronic medication monitors.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
HIV infected, marginally housed
18+ years old;
Initiating Atripla within 6-months of recruitment;
Lives in the Tenderloin, South of Market, or Mission District San Francisco;
Capable of providing informed consent; and
Willing to complete all study procedures.
Intoxication, cognitive dysfunction or psychosis will preclude potential subjects from informed consent.